Your browser doesn't support javascript.
loading
A Pituitary Society update to acromegaly management guidelines.
Fleseriu, Maria; Biller, Beverly M K; Freda, Pamela U; Gadelha, Monica R; Giustina, Andrea; Katznelson, Laurence; Molitch, Mark E; Samson, Susan L; Strasburger, Christian J; van der Lely, A J; Melmed, Shlomo.
Afiliación
  • Fleseriu M; Pituitary Center, Departments of Medicine and Neurological Surgery, Oregon Health & Science University, Portland, OR, USA.
  • Biller BMK; Neuroendocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Freda PU; Department of Medicine, Columbia University, Vagelos College of Physicians and Surgeons, New York, NY, USA.
  • Gadelha MR; Neuroendocrinology Research Center/Endocrinology Section, Medical School and Hospital Universitário Clementino Fraga Filho, Universidade Federal Do Rio de Janeiro, Rio de Janeiro, Brazil.
  • Giustina A; Institute of Endocrine and Metabolic Sciences, San Raffaele Vita-Salute University and IRCCS San Raffaele Hospital, Milan, Italy.
  • Katznelson L; Departments of Medicine and Neurosurgery, Stanford University School of Medicine, Stanford, CA, USA.
  • Molitch ME; Division of Endocrinology, Metabolism & Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Samson SL; Pituitary Center, Departments of Medicine and Neurosurgery, Baylor College of Medicine, Houson, TX, USA.
  • Strasburger CJ; Department of Medicine for Endocrinology, Diabetes and Nutritional Medicine, Charité Universitätsmedizin, Berlin, Germany.
  • van der Lely AJ; Pituitary Center Rotterdam, Endocrinology Section, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Melmed S; Pituitary Center, Cedars-Sinai Medical Center, 8700 Beverly Blvd., Room 2015, Los Angeles, CA, 90048, USA. melmed@csmc.edu.
Pituitary ; 24(1): 1-13, 2021 Feb.
Article en En | MEDLINE | ID: mdl-33079318
ABSTRACT
Guidelines and consensus statements ensure that physicians managing acromegaly patients have access to current information on evidence-based treatments to optimize outcomes. Given significant novel recent advances in understanding acromegaly natural history and individualized therapies, the Pituitary Society invited acromegaly experts to critically review the current literature in the context of Endocrine Society guidelines and Acromegaly Consensus Group statements. This update focuses on how recent key advances affect treatment decision-making and outcomes, and also highlights the likely role of recently FDA-approved therapies as well as novel combination therapies within the treatment armamentarium.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Acromegalia Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Pituitary Asunto de la revista: ENDOCRINOLOGIA Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Acromegalia Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Pituitary Asunto de la revista: ENDOCRINOLOGIA Año: 2021 Tipo del documento: Article